• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡介苗长期治疗黑色素瘤:它会抑制免疫能力吗?

Prolonged BCG treatment of melanoma: does it suppress the immune capacity?

作者信息

Helander I, Nordman E, Häkkinen I P, Toivanen A

出版信息

Br J Dermatol. 1979 Oct;101(4):421-7. doi: 10.1111/j.1365-2133.1979.tb00020.x.

DOI:10.1111/j.1365-2133.1979.tb00020.x
PMID:508607
Abstract

The immunological status of seven patients with disseminated melanoma during BCG scarification was followed. As parameters, the total peripheral blood leukocyte and lymphocyte counts, serum immunoglobulin levels, natural ABO blood group antibodies, lymphocyte responses in vitro to PHA and PPD, and skin reactivity against PPD and candidin were followed during a period of 2--36 months. The EAC-rosette-forming cells increased and the E-rosette-forming cells decreased during prolonged BCG therapy. The skin reactions and lymphocyte responses showed in most patients conversion from negative to positive or augmentation at the start of the therapy. Later on, however, the values in most patients dropped before disseminated disease became clinically apparent. In the only surviving patient the values first increased, remained high, and after 100 weeks treatment decreased. After 140 weeks' treatment immunological parameters are similar to pre-treatment levels. The possibility that prolonged intensive BCG treatment might eventually suppress the immune system, and thus result in an enhanced risk of dissemination of the disease, is discussed.

摘要

对7例播散性黑色素瘤患者在卡介苗划痕接种期间的免疫状态进行了跟踪观察。以全外周血白细胞和淋巴细胞计数、血清免疫球蛋白水平、天然ABO血型抗体、淋巴细胞体外对PHA和PPD的反应以及皮肤对PPD和念珠菌素的反应性作为参数,在2至36个月的时间内进行跟踪。在长期卡介苗治疗期间,EAC玫瑰花结形成细胞增加而E玫瑰花结形成细胞减少。在大多数患者中,皮肤反应和淋巴细胞反应在治疗开始时显示从阴性转为阳性或增强。然而,后来在播散性疾病临床显现之前,大多数患者的值下降。在唯一存活的患者中,这些值首先升高,保持在高位,在治疗100周后下降。在治疗140周后,免疫参数与治疗前水平相似。讨论了长期强化卡介苗治疗最终可能抑制免疫系统,从而导致疾病播散风险增加的可能性。

相似文献

1
Prolonged BCG treatment of melanoma: does it suppress the immune capacity?卡介苗长期治疗黑色素瘤:它会抑制免疫能力吗?
Br J Dermatol. 1979 Oct;101(4):421-7. doi: 10.1111/j.1365-2133.1979.tb00020.x.
2
The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.恶性黑色素瘤患者中卡介苗介导的肿瘤消退的免疫和组织病理学变化。
Cancer. 1975 Mar;35(3):756-77. doi: 10.1002/1097-0142(197503)35:3<756::aid-cncr2820350331>3.0.co;2-z.
3
Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.卡介苗和短小棒状杆菌对黑色素瘤患者免疫反应性的影响。
Dev Biol Stand. 1977;38:449-53.
4
Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781).结核菌素和卡介苗免疫反应性在Ⅰ期高危恶性黑色素瘤中的预后价值(欧洲癌症研究与治疗组织方案18781)
Dermatology. 1996;193(2):105-9. doi: 10.1159/000246222.
5
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.微小棒状杆菌和卡介苗疗法对播散性黑色素瘤患者免疫参数的影响:一项为期28天的序贯研究。I. 血细胞计数、血清免疫球蛋白和淋巴细胞群体的变化
Clin Exp Immunol. 1979 Jan;35(1):36-44.
6
Immunological changes in cancer patients receiving BCG.接受卡介苗治疗的癌症患者的免疫变化。
Dev Biol Stand. 1977;38:441-8.
7
Intralesional immunotherapy of melanoma with BCG.卡介苗对黑色素瘤的瘤内免疫疗法。
Med Clin North Am. 1976 May;60(3):419-30. doi: 10.1016/s0025-7125(16)31889-2.
8
The use of oral BCG in the treatment or metastatic malignant melanoma.口服卡介苗在治疗转移性恶性黑色素瘤中的应用。
Med Pediatr Oncol. 1976;2(2):173-81. doi: 10.1002/mpo.2950020207.
9
Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.复发性转移性皮肤恶性黑色素瘤的病灶内治疗:卡介苗与二硝基氯苯病灶内注射的随机前瞻性研究
Cancer. 1978 Jun;41(6):2456-63. doi: 10.1002/1097-0142(197806)41:6<2456::aid-cncr2820410654>3.0.co;2-b.
10
Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving BCG immunotherapy.接受卡介苗免疫疗法的恶性黑色素瘤患者淋巴细胞增殖能力的序贯检测
Int J Cancer. 1977 Jan;19(1):18-26. doi: 10.1002/ijc.2910190104.

引用本文的文献

1
Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy.卡介苗病灶内免疫疗法治疗牛眼鳞状细胞癌后的免疫反应性
Cancer Immunol Immunother. 1986;22(2):87-94. doi: 10.1007/BF00199120.